Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohort

BACKGROUND: To determine if testosterone levels are influenced by dopaminergic therapy in Parkinson disease (PD) patients. Testosterone level has been reported to be low in patients with PD and other neurodegenerative diseases. In this study, we sought to determine whether dopaminergic therapy (i.e....

Descripción completa

Detalles Bibliográficos
Autores principales: Okun, Michael S, Wu, Samuel S, Jennings, Dana, Marek, Kenneth, Rodriguez, Ramon L, Fernandez, Hubert H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711001/
https://www.ncbi.nlm.nih.gov/pubmed/26788334
http://dx.doi.org/10.1186/2054-7072-1-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711001/
https://www.ncbi.nlm.nih.gov/pubmed/26788334
http://dx.doi.org/10.1186/2054-7072-1-8

Ejemplares similares